CVCM

CureVac AG

Application Filed: 2019-05-23
Trademark Application Details
Trademark Logo CVCM

Mark For: CVCM™ trademark registration is intended to cover the categories of chemical reagents and biomolecules, in particular biological macromolecules in the nature of nucleic acid for industrial or scientific purposes; Reagents for research purposes. [all]

Status

2020-04-27 UTC
LIVE APPLICATION Published for Opposition
A pending trademark application has been examined by the Office and has been published in a way that provides an opportunity for the public to oppose its registration.


Research OneLook Acronym Finder
Serial Number88444536
Mark Literal ElementsCVCM
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTRADEMARK. SERVICE MARK
RegisterPRINCIPAL
Current LocationPUBLICATION AND ISSUE SECTION 2020-03-11
Basis44(e)
Class StatusACTIVE
Primary US Classes
  • 001: Raw or Partly Prepared Materials
  • 005: Adhesives
  • 006: Chemicals and Chemical Compositions
  • 010: Fertilizers
  • 026: Measuring and Scientific Appliances
  • 046: Foods and Ingredients of Foods
Primary International Class
  • 001 - Primary Class
  • (Chemicals) Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
Filed UseNo
Current UseNo
Intent To UseNo
Filed ITUNo
44D FiledYes
44E CurrentYes
66A CurrentNo
Current BasisNo
No BasisNo
Domestic RepresentativeJennifer Fraser
Attorney NameJennifer Fraser
Attorney Docket Number067249-0053
Law Office AssignedL50
Employee NameTENG, SIMON

Timeline

2019-05-23Application Filed
2019-08-13Location: TMEG LAW OFFICE 105 - EXAMINING ATTORNEY ASSIGNED
2019-08-13Status: Live/Pending
2019-08-13Transaction Date
2019-10-29Trademark Registered
2020-03-11Location: PUBLICATION AND ISSUE SECTION
2020-04-14Published
2020-04-14Status: Application has been published for opposition. The opposition period begins on the date of publication.

Trademark Parties (Applicants & Owners)

Party: CureVac AG
AddressPaul-Ehrlich-Str. 15 Tübingen GERMANY 72076
Legal Entity TypeAktiengesellschaft (ag)
Legal Entity StateGERMANY

Documents

DrawingJPEG2019-05-23
TEAS RF New ApplicationMULTI2019-05-23
Notation to FileXML2019-08-13
Offc Action OutgoingXML2019-08-13
XSearch Search SummaryXML2019-08-13
Response to Office ActionAPPLICATION/XML2020-02-03
Amendment and Mail Process CompleteAPPLICATION/XML,IMAGE/JPEG2020-02-11
Suspension LetterXML2020-02-22
TEAS Response to Suspension InquiryMULTI2020-03-02
Amendment and Mail Process CompleteMULTI2020-03-06
TRAM Snapshot of App at Pub for OppostnAPPLICATION/XML,IMAGE/JPEG2020-03-07
Notice of PublicationXML2020-03-25
Notification Of Notice of PublicationXML2020-03-25
OG Publication ConfirmationAPPLICATION/XML2020-04-14

Attorney of Record

JENNIFER FRASER
DYKEMA GOSSETT PLLC
1301 K ST., NW
SUITE 1100 WEST
WASHINGTON, DC 20005

Good, Services, and Codes


IC 001. US 001 005 006 010 026 046. G & S: Chemical reagents and biomolecules, in particular biological macromolecules in the nature of nucleic acid for industrial or scientific purposes; Reagents for research purposes
IC 005. US 006 018 044 046 051 052. G & S: Chemical preparations for medical use, namely, for therapeutic and prophylactic treatment of neurological, neuromuscular, neurodegenerative, infectious and cardiovascular diseases, of autoimmune diseases and tumours, of allergies, of metabolic diseases, of heritable genetic diseases, and for therapies replacing proteins or enzymes; pharmaceutical preparations, namely, immunostimulants, in particular for human or veterinary medical purposes; pharmaceutical preparations, namely, vaccines, in particular for human or veterinary medical purposes; pharmaceutical preparations, namely, adjuvant immunostimulants; pharmaceuticals and medicaments containing biological macromolecules, in particular for human or veterinary purposes for the treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, for the treatment of infectious diseases, autoimmune diseases and tumours, for treatment of metabolic diseases and for treatment of heritable genetic diseases and for protein or enzyme replacement therapy; gene therapy products, namely, nucleic acid macromolecules for in vivo expression for human or veterinary medical use; Dietetic substances adapted for medical use, in particular substances for food supplements, namely, dietary food supplements
IC 042. US 100 101. G & S: Scientific and technological services, namely, technical biology consulting and scientific research services, in particular for identifying and characterizing biological macromolecules; pre-clinical and clinical testing of macromolecules
IC 044. US 100 101. G & S: Medical and veterinary services, in particular for therapeutic and preventative treatment of tumour diseases, infectious diseases, autoimmune disorders and allergies, for treatment of inherited genetic diseases or for protein or enzyme replacement therapy, and for treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, and for treatment of metabolic disorders

International Codes:1
U.S. Codes:001,005,006,010,026,046
International Codes:5
U.S. Codes:006,018,044,046,051,052
International Codes:42
U.S. Codes:100,101
International Codes:44
U.S. Codes:100,101
Type CodeType
GS0011Chemicals and biomolecules, in particular biological macromolecules, for industrial or scientific purposes; Reagents for research purposes
GS0011Chemical reagents and biomolecules, in particular biological macromolecules in the nature of nucleic acid for industrial or scientific purposes; Reagents for research purposes

Trademark Filing History

DescriptionDateProceeding Number
PUBLISHED FOR OPPOSITION2020-04-14
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2020-04-14
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2020-03-25
APPROVED FOR PUB - PRINCIPAL REGISTER2020-03-06
TEAS/EMAIL CORRESPONDENCE ENTERED2020-03-0570629
CORRESPONDENCE RECEIVED IN LAW OFFICE2020-03-0570629
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED2020-03-02
SUSPENSION LETTER WRITTEN2020-02-2283698
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED2020-02-226332
LETTER OF SUSPENSION E-MAILED2020-02-226332
TEAS/EMAIL CORRESPONDENCE ENTERED2020-02-1070629
CORRESPONDENCE RECEIVED IN LAW OFFICE2020-02-1070629
ASSIGNED TO LIE2020-02-1070629
TEAS RESPONSE TO OFFICE ACTION RECEIVED2020-02-03
NOTIFICATION OF NON-FINAL ACTION E-MAILED2019-08-136325
NON-FINAL ACTION WRITTEN2019-08-1383698
NON-FINAL ACTION E-MAILED2019-08-136325
ASSIGNED TO EXAMINER2019-08-1083698
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2019-06-08
NEW APPLICATION ENTERED IN TRAM2019-05-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed